These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27471467)

  • 1. A Missense Mutation of the Gene Encoding Synaptic Vesicle Glycoprotein 2A (SV2A) Confers Seizure Susceptibility by Disrupting Amygdalar Synaptic GABA Release.
    Tokudome K; Okumura T; Terada R; Shimizu S; Kunisawa N; Mashimo T; Serikawa T; Sasa M; Ohno Y
    Front Pharmacol; 2016; 7():210. PubMed ID: 27471467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synaptic vesicle glycoprotein 2A (SV2A) regulates kindling epileptogenesis via GABAergic neurotransmission.
    Tokudome K; Okumura T; Shimizu S; Mashimo T; Takizawa A; Serikawa T; Terada R; Ishihara S; Kunisawa N; Sasa M; Ohno Y
    Sci Rep; 2016 Jun; 6():27420. PubMed ID: 27265781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Function of synaptic vesicle protein 2A (SV2A) as a novel therapeutic target for epilepsy].
    Tokudome K; Shimizu S; Serikawa T; Ohno Y
    Nihon Yakurigaku Zasshi; 2018; 152(6):275-280. PubMed ID: 30531097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Role of Synaptic Vesicle Glycoprotein 2A (SV2A) in Modulating Epileptogenesis.
    Ohno Y; Tokudome K
    CNS Neurol Disord Drug Targets; 2017; 16(4):463-471. PubMed ID: 28393712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferential increase in the hippocampal synaptic vesicle protein 2A (SV2A) by pentylenetetrazole kindling.
    Ohno Y; Ishihara S; Terada R; Kikuta M; Sofue N; Kawai Y; Serikawa T; Sasa M
    Biochem Biophys Res Commun; 2009 Dec; 390(3):415-20. PubMed ID: 19751703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kindling-associated SV2A expression in hilar GABAergic interneurons of the mouse dentate gyrus.
    Ohno Y; Okumura T; Terada R; Ishihara S; Serikawa T; Sasa M
    Neurosci Lett; 2012 Feb; 510(2):93-8. PubMed ID: 22266237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal low-frequency stimulation increased SV2A expression and inhibited the seizure degree in pharmacoresistant amygdala-kindling epileptic rats.
    Wang L; Shi J; Wu G; Zhou F; Hong Z
    Epilepsy Res; 2014 Nov; 108(9):1483-91. PubMed ID: 25205164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synaptic vesicle protein2A decreases in amygdaloid-kindling pharmcoresistant epileptic rats.
    Shi J; Zhou F; Wang LK; Wu GF
    J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):716-722. PubMed ID: 26489628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proepileptic phenotype of SV2A-deficient mice is associated with reduced anticonvulsant efficacy of levetiracetam.
    Kaminski RM; Gillard M; Leclercq K; Hanon E; Lorent G; Dassesse D; Matagne A; Klitgaard H
    Epilepsia; 2009 Jul; 50(7):1729-40. PubMed ID: 19486357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synaptic Vesicle Glycoprotein 2A: Features and Functions.
    Rossi R; Arjmand S; Bærentzen SL; Gjedde A; Landau AM
    Front Neurosci; 2022; 16():864514. PubMed ID: 35573314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of SV2A in hippocampal glutamatergic and GABAergic terminals during postnatal development.
    Vanoye-Carlo A; Gómez-Lira G
    Brain Res; 2019 Jul; 1715():73-83. PubMed ID: 30905653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synaptic vesicle glycoprotein 2A modulates vesicular release and calcium channel function at peripheral sympathetic synapses.
    Vogl C; Tanifuji S; Danis B; Daniels V; Foerch P; Wolff C; Whalley BJ; Mochida S; Stephens GJ
    Eur J Neurosci; 2015 Feb; 41(4):398-409. PubMed ID: 25484265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synaptic Vesicle Protein 2A Expression in Glutamatergic Terminals Is Associated with the Response to Levetiracetam Treatment.
    Contreras-García IJ; Gómez-Lira G; Phillips-Farfán BV; Pichardo-Macías LA; García-Cruz ME; Chávez-Pacheco JL; Mendoza-Torreblanca JG
    Brain Sci; 2021 Apr; 11(5):. PubMed ID: 33922424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Connectivity Mapping Using a Novel
    Zhang Y; Heylen L; Partoens M; Mills JD; Kaminski RM; Godard P; Gillard M; de Witte PAM; Siekierska A
    Front Mol Neurosci; 2022; 15():881933. PubMed ID: 35686059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imbalance of glutamatergic and GABAergic neurotransmission in audiogenic seizure-susceptible L
    Kinboshi M; Shimizu S; Tokudome K; Mashimo T; Serikawa T; Ito H; Takahashi R; Ikeda A; Ohno Y
    Heliyon; 2023 Jul; 9(7):e17984. PubMed ID: 37539249
    [No Abstract]   [Full Text] [Related]  

  • 16. Scn1a missense mutation impairs GABAA receptor-mediated synaptic transmission in the rat hippocampus.
    Ohno Y; Sofue N; Ishihara S; Mashimo T; Sasa M; Serikawa T
    Biochem Biophys Res Commun; 2010 Sep; 400(1):117-22. PubMed ID: 20707984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Differential Expression of Synaptic Vesicle Protein 2A in the Adult Rat Brain.
    Mendoza-Torreblanca JG; García-Cruz ME; Sánchez-Cruz I; Gomez-Gonzalez B; Juárez-Méndez S; Gómez-Lira G
    Neuroscience; 2019 Nov; 419():108-120. PubMed ID: 31520710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of levetiracetam on molecular regulation of hippocampal glutamate and GABA transporters in rats with chronic seizures induced by amygdalar FeCl3 injection.
    Ueda Y; Doi T; Nagatomo K; Tokumaru J; Takaki M; Willmore LJ
    Brain Res; 2007 Jun; 1151():55-61. PubMed ID: 17408599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond.
    Löscher W; Gillard M; Sands ZA; Kaminski RM; Klitgaard H
    CNS Drugs; 2016 Nov; 30(11):1055-1077. PubMed ID: 27752944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of synaptic vesicle protein 2A after status epilepticus and during epilepsy in a lithium-pilocarpine model.
    Contreras-García IJ; Pichardo-Macías LA; Santana-Gómez CE; Sánchez-Huerta K; Ramírez-Hernández R; Gómez-González B; Rocha L; Mendoza Torreblanca JG
    Epilepsy Behav; 2018 Nov; 88():283-294. PubMed ID: 30336420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.